-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$16.00-18.16% Downside
ADMA Biologics, Inc. Frequently Asked Questions
-
What analysts cover ADMA Biologics, Inc.?
ADMA Biologics, Inc. has been rated by research analysts at H.C. Wainwright, Mizuho Securities in the past 90 days.